You Cannot Split a 500 mg Robaxin Tablet to Achieve a 750 mg Dose
Splitting a single 500 mg Robaxin (methocarbamol) tablet cannot produce a 750 mg dose—this is mathematically impossible, as half of 500 mg equals 250 mg, not the additional 250 mg needed to reach 750 mg.
The Mathematical Reality
To achieve a 750 mg dose of methocarbamol, you would need:
- One and a half 500 mg tablets (500 mg + 250 mg = 750 mg)
- This requires splitting one tablet in half and adding it to a whole tablet
Critical Considerations About Tablet Splitting
Dose Accuracy Concerns
While the mathematics work out, tablet splitting introduces significant dose variability that may be clinically relevant:
- Research demonstrates that split tablets frequently fail uniformity standards, with 15-16% of half-tablets falling outside acceptable weight and content specifications 1
- Studies show that even scored tablets can produce half-tablets with drug content ranging from 52-133% of the intended dose 2
- Weight variation does not reliably predict drug content variation—fragments may appear equal in size but contain substantially different amounts of active drug 1, 3
Practical Implications for Methocarbamol
For methocarbamol specifically:
- The drug has a relatively wide therapeutic index and is used for muscle spasm relief, not life-threatening conditions
- Standard dosing ranges from 1,000-1,500 mg three to four times daily initially, with maintenance doses of 750-1,000 mg every 4 hours 4
- The 10-20% dose variation commonly seen with tablet splitting is unlikely to cause serious clinical consequences given the drug's safety profile
Recommendations
If you must achieve a 750 mg dose:
- Use one whole 500 mg tablet plus one-half of another 500 mg tablet
- Use a proper tablet splitter rather than a knife (though this only marginally improves uniformity)
- Have the same person split all tablets to maintain consistency
- Consider whether the prescriber could instead order 750 mg tablets if available, or adjust to 500 mg or 1,000 mg dosing to avoid splitting entirely
Common pitfall to avoid: Do not assume that visually equal tablet fragments contain equal drug amounts—appearance is not a reliable indicator of dose uniformity 1.